CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-06 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,895 | $32.27 | $126K | 69,360 |
| 2021-10-06 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 77,900 | ||
| 2021-10-06 | Cohen Chad M Chief Financial Officer | Option exercise | +5,000 | $7.27 | $36K | 26,604 |
| 2021-10-06 | Cohen Chad M Chief Financial Officer | Sale | −5,000 | $32.30 | $162K | 21,604 |
| 2021-10-06 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 100,000 | ||
| 2021-10-05 | Cohen Chad M Chief Financial Officer | Option exercise | +5,000 | $7.27 | $36K | 26,604 |
| 2021-10-05 | Cohen Chad M Chief Financial Officer | Sale | −5,000 | $32.51 | $163K | 21,604 |
| 2021-10-05 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 105,000 | ||
| 2021-09-15 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-09-15 | ROBINS HARLAN S Chief Scientific Officer | Sale | −2,995 | $36.52 | $109K | 70,260 |
| 2021-09-15 | ROBINS HARLAN S Chief Scientific Officer | Sale | −900 | $37.23 | $34K | 69,360 |
| 2021-09-15 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 81,795 | ||
| 2021-09-14 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-09-14 | ROBINS HARLAN S Chief Scientific Officer | Sale | −2,795 | $36.49 | $102K | 70,460 |
| 2021-09-14 | ROBINS HARLAN S Chief Scientific Officer | Sale | −1,100 | $37.36 | $41K | 69,360 |
| 2021-09-14 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 85,690 | ||
| 2021-09-13 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-09-13 | ROBINS HARLAN S Chief Scientific Officer | Sale | −2,995 | $37.39 | $112K | 70,260 |
| 2021-09-13 | ROBINS HARLAN S Chief Scientific Officer | Sale | −900 | $37.89 | $34K | 69,360 |
| 2021-09-13 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 89,585 |
Page 40 of 120 · 2,386 trades